United States · FDA National Drug Code directory
Xermelo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70720-125_8643b325-c079-4319-b751-223180291f0a
- Product NDC
- 70720-125
- Form
- TABLET
- Composition / generic term
- telotristat ethyl
- Labeler
- TerSera Therapeutics LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201005
- Source listing expiry
- 20271231
Source-listed ingredients
- TELOTRISTAT ETHYL — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BOX in 1 CASE (70720-125-85) / 1 BLISTER PACK in 1 BOX (70720-125-22) / 21 TABLET in 1 BLISTER PACK · 70720-125-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →